Results for tag: "Vpriv"

Vpriv is a medication used to treat endocrine and metabolic disorders. It is a recombinant human enzyme, which is used to replace the deficient enzyme in patients with Gaucher disease type 1. Vpriv is a form of enzyme replacement therapy (ERT) and is the only approved ERT for this condition. It is administered as a subcutaneous injection and works by breaking down certain fatty substances in the body. Vpriv is also used to treat Fabry disease, a rare genetic disorder that affects the body's ability to break down certain fats. Vpriv is marketed by Shire, a global biopharmaceutical company. Other companies in the market include Genzyme, a biotechnology company, and Amicus Therapeutics, a biopharmaceutical company focused on rare and orphan diseases. Show Less Read more